Best practices in the use of human immunoglobulin preparations for intravenous administration in the treatment of rare neurological diseases
Open Access
- 21 April 2023
- journal article
- research article
- Published by Siberian State Medical University in Bulletin of Siberian Medicine
- Vol. 22 (1) , 174-182-182
Abstract
Aim. To describe best practices in using human normal immunoglobulin in patients with immune-mediated neurological disorders according to the data of one clinical center.Materials and methods. From 2016 to 2021, 20 patients with various autoimmune disorders of the peripheral and central nervous system were treated with human normal immunoglobulin at the Neurology Unit No.1 of Pavlov First Saint Petersburg State Medical University. Treatment efficacy was assessed by changes in the neurological examination data according to specialized scales for specific diseases or clinical manifestations (INCAT, QMGS, MoCA, EDSS). Safety of the therapy was assessed considering the instructions to the drug.Results. In the vast majority of patients, treatment allowed to stabilize the course of the disease or was accompanied by pronounced regression.Conclusion. The considered clinical cases of the use of human normal immunoglobulin preparations demonstrate the possibility of their use in the treatment of a number of autoimmune neurological diseases for unregistered indications.Keywords
This publication has 20 references indexed in Scilit:
- Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviewsCochrane Database of Systematic Reviews, 2017
- Efficacy of Intravenous Immunoglobulin in Neurological DiseasesNeurotherapeutics, 2016
- The Diagnosis and Treatment of Autoimmune EncephalitisJournal of Clinical Neurology, 2016
- Intravenous immunoglobulins: perspectives in multiple sclerosis (a literature review with own results)S.S. Korsakov Journal of Neurology and Psychiatry, 2015
- The place of intravenous immunoglobulin in rheumatic diseasesModern Rheumatology Journal, 2015
- Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)Journal of Neurology, 2013
- The Safety Profile of Home Infusion of Intravenous Immunoglobulin in Patients With Neuroimmunologic DisordersJournal of Clinical Neuromuscular Disease, 2011
- European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of multifocal motor neuropathy. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society – first revisionJournal of the Peripheral Nervous System, 2010
- European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society — First RevisionEuropean Journal of Neurology, 2010
- Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosisJournal of Neurology, 2004